US03969K1088
US03969K1088
Arcutis Biotherapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 376.072.000 | 196.542.000 | 91.3% |
| Cost of Revenue | 36.695.000 | 19.128.000 | 91.8% |
| Gross Profit | 339.377.000 | 177.414.000 | 91.3% |
| 351.604.000 | 305.811.000 | 15.0% | |
| Operating Income | -12.227.000 | -128.397.000 | 90.5% |
| Pretax Income | -14.970.000 | -139.392.000 | 89.3% |
| Net Income Common Stockholders | -16.141.000 | -140.039.000 | 88.5% |
| -- | -- | -- | |
| -- | -- | -- |